VYNE Therapeutics  logo
VYNE Therapeutics VYNE
$ 2.84 0.71%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VYNE Therapeutics Long Term Debt Current 2011-2024 | VYNE

Annual Long Term Debt Current VYNE Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
115 K - 349 K 757 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
757 K 115 K 407 K